Results 101 to 110 of about 23,073,058 (182)

Pharmacoeconomic Analysis of Fixed-Dose Combinations of Proton Pump Inhibitors Available in India. [PDF]

open access: yesCureus, 2023
Deolekar P   +7 more
europepmc   +1 more source

Pharmacoeconomic analysis (CER) of Dulaglutide and Liraglutide in the treatment of patients with type 2 diabetes. [PDF]

open access: yesFront Endocrinol (Lausanne), 2023
Su Y   +8 more
europepmc   +1 more source

Pharmacoeconomic Analysis of the Different Therapeutic Approaches in Control of Bovine Mastitis: Phytotherapy and Antimicrobial Treatment. [PDF]

open access: yesAntibiotics (Basel), 2022
Kovačević Z   +6 more
europepmc   +1 more source

National and Individual‐Level Economic Burden of Local Corticosteroid Use and Concomitant Use of Multiple Local Corticosteroid Formulations—A Nationwide Cohort Study

open access: yes
Clinical &Experimental Allergy, Volume 56, Issue 10, Page 1230-1232, October 2026.
Kjell Erik Julius Håkansson   +11 more
wiley   +1 more source

Prescribing patterns and pharmacoeconomic analysis of antihypertensive drugs in South Indian population: A cross-sectional study. [PDF]

open access: yesPerspect Clin Res, 2023
Shanmugapriya S   +5 more
europepmc   +1 more source

Pharmacoeconomic analysis of adjuvant use of zonisamide therapy resistant partial epilepsy in adults [PDF]

open access: yes, 2018
The purpose of pharmacoeconomic studies of the drug zonisamide is to determine it’s clinical and cost-effectiveness in adult patients with refractory partial epilepsy in comparison with other new antiepileptic drugs in the conditions of the Russian ...
D. Yu. Belousov   +2 more
core  

SEARCH OF INFORMATION IN PHARMACOECONOMIC RESEARCH

open access: yes, 2015
in this paper it’s represented the information search methods review, that is used in pharmacoeconomic studies.
V. G. Serpik   +2 more
core  

Principles of pharmacoeconomic analysis: the case of pharmacist-led interventions. [PDF]

open access: yesPharm Pract (Granada), 2021
Tonin FS   +4 more
europepmc   +1 more source

PHARMACOECONOMIC ANALYSIS OF DOCETAXEL IN THE ADJUVANT THERAPY OF BREAST CANCER

open access: yesФармакоэкономика, 2015
Based on a clinical study BCIRG 001 (Martin M., Mackey J., Pienkowski T.) and as an outcome of Markov simulation it was determined that the use of 6DAC for adjuvant therapy in 10 year horizon of research allows to increase the disease-free survival by 6 ...
R. I. Yagudina, I. Yu. Zinchuk
doaj  

Home - About - Disclaimer - Privacy